TR201204288A2 - Levodopa, karbidopa, entakapon içeren tablet formülasyonu. - Google Patents

Levodopa, karbidopa, entakapon içeren tablet formülasyonu.

Info

Publication number
TR201204288A2
TR201204288A2 TR2012/04288A TR201204288A TR201204288A2 TR 201204288 A2 TR201204288 A2 TR 201204288A2 TR 2012/04288 A TR2012/04288 A TR 2012/04288A TR 201204288 A TR201204288 A TR 201204288A TR 201204288 A2 TR201204288 A2 TR 201204288A2
Authority
TR
Turkey
Prior art keywords
entacapone
carbidopa
formulation containing
tablet formulation
containing levodopa
Prior art date
Application number
TR2012/04288A
Other languages
English (en)
Inventor
Kesgi̇n Di̇dehan
Bulgur Abdullah
Original Assignee
Ali̇ Rai̇f İlaç Sanayi̇ A.Ş.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ali̇ Rai̇f İlaç Sanayi̇ A.Ş. filed Critical Ali̇ Rai̇f İlaç Sanayi̇ A.Ş.
Priority to TR2012/04288A priority Critical patent/TR201204288A2/tr
Publication of TR201204288A2 publication Critical patent/TR201204288A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Levodopa, karbidopa, entakapon veya bu moleküllerin farmasötik olarak kabul edilebilir tuzlarını, solvatlarını veya hidratlarını içeren ve bir veya daha fazla eksipiyan içeren, Parkinson hastalığının tedavisi amacı ile hazırlanan katı formda, stabil çift tabakalı bir kompozisyon ile ilgilidir.
TR2012/04288A 2012-04-13 2012-04-13 Levodopa, karbidopa, entakapon içeren tablet formülasyonu. TR201204288A2 (tr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2012/04288A TR201204288A2 (tr) 2012-04-13 2012-04-13 Levodopa, karbidopa, entakapon içeren tablet formülasyonu.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2012/04288A TR201204288A2 (tr) 2012-04-13 2012-04-13 Levodopa, karbidopa, entakapon içeren tablet formülasyonu.

Publications (1)

Publication Number Publication Date
TR201204288A2 true TR201204288A2 (tr) 2012-12-21

Family

ID=47679801

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2012/04288A TR201204288A2 (tr) 2012-04-13 2012-04-13 Levodopa, karbidopa, entakapon içeren tablet formülasyonu.

Country Status (1)

Country Link
TR (1) TR201204288A2 (tr)

Similar Documents

Publication Publication Date Title
MX2016016666A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2016015093A (es) Derivados de acido boronico y sus usos terapeuticos.
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2015008628A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
CL2015000942A1 (es) Compuestos de benceno sustituido.
EA201690107A1 (ru) Фармацевтическая композиция, содержащая диметилфумарат, для введения в низкой суточной дозе
SG10201810985XA (en) Tofacitinib oral sustained release dosage forms
MX2014009757A (es) Derivados de isoindolina, composiciones farmaceuticas que los contienen y su uso en terapia.
MX2015003959A (es) Inhibidores de histona demetilasas.
MY162146A (en) Pharmaceutical composition
MY157673A (en) Pharmaceutical compositions comprising hydromorphone and naloxone
MX2016002580A (es) Combinacion de un inhibidor de alk y un inhibidor de cdk para el tratamiento de enfermedades celulares proliferativas.
TR201906685T4 (tr) Kristalin macitentan içeren farmasötik bileşim.
TR201009394A2 (tr) Geliştirilmiş montelukast formülasyonları.
EP2656856A3 (en) Tablet formulation comprising levodopa, carbidopa, entacapone providing extended release
MX356789B (es) Composición de difenidol de liberación prolongada.
NZ717192A (en) Anti-inflammatory tripeptides
MX369778B (es) Potenciadores de solubilidad del agua a base de glucogeno.
TR201815617A2 (tr) Deksketoprofen içeren bir formülasyon.
PH12016500120A1 (en) Anti-tuberculosis stable pharmaceutical composition in a form of a coated tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation
MX363558B (es) Composiciones farmaceuticas que comprenden flurbiprofeno.
TR201007926A1 (tr) Prasugrel tablet formülasyonları.
EA201590732A1 (ru) Диспергируемая таблетка
TR201204288A2 (tr) Levodopa, karbidopa, entakapon içeren tablet formülasyonu.
EA201500446A1 (ru) Фармацевтическая композиция для снижения уровня n-оксида триметиламина